Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

fiercebiotech.com

FierceBiotech

Get the latest updates from FierceBiotech directly as they happen.

Follow now 332 followers

Latest posts

Last updated 15 minutes ago

Asahi Kasei scoops up Germany's Aicuris for $920M in R&D portfolio boost

15 minutes ago

Japanese conglomerate Asahi Kasei is acquiring Aicuris in a $920 million deal...

Charles River sells manufacturing and discovery businesses to fulfill promised pivot

about 12 hours ago

After promising to sell off 7% of its business back in November...

Worried Trump's MFN push will ‘destroy biotech innovation,’ midsize companies form coalition to fight back

about 13 hours ago

In an effort to battle against what members feel is an existential...

ARPA-H designates up to $144M for anti-aging medical research

about 14 hours ago

The federal government is pledging as much as $144 million to anti-aging...

After gene therapy exit, Pfizer locks in global license for Beam gene editing candidate

about 17 hours ago

After dumping its sole remaining gene therapy asset last year, Pfizer has...

Novo Nordisk inks $2.1B pact with Langer startup to boost oral drug delivery prowess

about 18 hours ago

Following the launch of its Wegovy (semaglutide) pill at the beginning of...

GSK pays $950M in cash for Canadian biotech and its Winrevair-like blood pressure drug

about 21 hours ago

Like Merck & Co.’s PAH drug Winrevair—which brought in $1.4 billion last...

Werewolf weighs sale or merger as cash reserves whimper

1 day ago

With its cash cache set to run out by the fourth quarter...

After 230% deal size explosion, China is no longer the 'bargain basement' for biopharma licensing: analyst

1 day ago

The average upfront value for a licensing deal between a Western biotech...

Harbour ships CTLA-4 asset to form new biotech in $1.1B biobucks deal

1 day ago

Harbour BioMed is setting sail as the Solstice begins, riding the waves...

FDA freezes enrollment in MacroGenics cancer trial after patient death

1 day ago

The FDA has ordered MacroGenics to halt enrollment in a phase 2...

Evinova reels in AI clinical development deals with Astellas and AstraZeneca

1 day ago

Astellas Pharma and AstraZeneca are joining Bristol Myers Squibb by partnering with...